X4pharma

X4 Pharmaceuticals develops therapeutics focused on rare immune disorders. The company's pipeline targets the CXCR4 pathway to address unmet medical needs in these patient populations. They are driving progress for individuals living with chronic conditions like neutropenia.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

X4 Pharmaceuticals develops therapeutics focused on rare immune disorders. The company's pipeline targets the CXCR4 pathway to address unmet medical needs in these patient populations. They are driving progress for individuals living with chronic conditions like neutropenia.